Publikationen, an denen er mitarbeitet Jana Alonso Lorenzo (10)

2019

  1. Proteomic studies reveal disrupted in schizophrenia 1 as a player in both neurodevelopment and synaptic function

    International Journal of Molecular Sciences, Vol. 20, Núm. 1

2015

  1. Key structural and functional differences between early and advanced glycation products

    Journal of Molecular Endocrinology, Vol. 56, Núm. 1, pp. 23-37

2014

  1. Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: Its downregulation by DISC1

    Human Molecular Genetics, Vol. 23, Núm. 22, pp. 5859-5865

2012

  1. A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: Implications for CLEC-2 signaling regulation

    Blood, Vol. 120, Núm. 26

  2. DISC-1 regula la expresión del neuropéptido antidepresivo VGF en neuronas

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 54-54

2011

  1. High-resolution two-dimensional gel electrophoresis analysis of atrial tissue proteome reveals down-regulation of fibulin-1 in atrial fibrillation

    International Journal of Cardiology, Vol. 150, Núm. 3, pp. 283-290

  2. Variations in platelet proteins associated with st-elevation myocardial infarction: Novel clues on pathways underlying platelet activation in acute coronary syndromes

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, Núm. 12, pp. 2957-2964

2010

  1. Identificación mediante proteómica de posibles biomarcadores plaquetarios en síndome coronario agudo

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 5, pp. 35-36

  2. Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: A proteomic study

    PLoS ONE, Vol. 5, Núm. 10

2009

  1. High resolution 2-De-Based proteomics analysis of human atrial fibrilation

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 125-125